FDA Drug recall D-1232-2014
Lidiy capsules Dietary Supplement
- FDA Drug
- Class I
- terminated
- Published 2014-04-23
On 2014-04-23 the FDA classified a Class I recall of Lidiy capsules Dietary Supplement by B B Trade, citing marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1232-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-10-07 |
| Published | 2014-04-23 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | B B Trade |
| Distribution | US |
Product
Lidiy capsules Dietary Supplement. Each bottle contains 30 capsules.
Reason
Marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine
Identifiers
| code_info | ALL LOTS |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1232-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.